Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction. - Wikidata - wikimedia - TriplyDB

Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction.

Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction.

http://www.wikidata.org/entity/Q33817996

about

NFAT regulates the expression of AIF-1 and IRT-1: yin and yang splice variants of neointima formation and atherosclerosis Inflammation, immunity, and hypertensive end-organ damage Vascular IL-10: a protective role in preeclampsia.The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the Heart Calcific aortic valve stenosis: methods, models, and mechanisms Leukocyte-dependent responses of the microvasculature to chronic angiotensin II exposure Dual opposing roles of adaptive immunity in hypertension.Role of Interleukin-10 in Acute Brain Injuries.Sex differences in protection against angiotensin II-induced endothelial dysfunction by manganese superoxide dismutase in the cerebral circulation.Captopril reduces cardiac inflammatory markers in spontaneously hypertensive rats by inactivation of NF-kB Vascular endothelial function and hypertension: insights and directions Angiotensin II-induced endothelial dysfunction is temporally linked with increases in interleukin-6 and vascular macrophage accumulation.Inflammation, immunity, and hypertension.Immunosuppressive/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction--a novel mechanism for maintaining vascular function Terminal arteriolar network structure/function and plasma cytokine levels in db/db and ob/ob mouse skeletal muscle.Protecting against vascular disease in brain Transthyretin is dysregulated in preeclampsia, and its native form prevents the onset of disease in a preclinical mouse model.Identification of key contributory factors responsible for vascular dysfunction in idiopathic recurrent spontaneous miscarriage.Role of T lymphocytes in hypertension.Interleukin-10: a pleiotropic regulator in pregnancy.Immune Mechanisms in Arterial Hypertension.Vascular inflammatory cells in hypertension.Impact of eNOS-Dependent Oxidative Stress on Endothelial Function and Neointima Formation.Radiation damage and radioprotectants: new concepts in the era of molecular medicine Interleukin-10 released by CD4(+)CD25(+) natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice.Small-molecule inhibitors of signal transducer and activator of transcription 3 protect against angiotensin II-induced vascular dysfunction and hypertension Association of interleukin-10 gene promoter polymorphisms with recurrent pregnancy loss: a meta-analysis.Interdependencies among Selected Pro-Inflammatory Markers of Endothelial Dysfunction, C-Peptide, Anti-Inflammatory Interleukin-10 and Glucose Metabolism Disturbance in Obese Women Context-dependent effects of SOCS3 in angiotensin II-induced vascular dysfunction and hypertension in mice: mechanisms and role of bone marrow-derived cells Interleukin-10 protects against aging-induced endothelial dysfunction.Decrease in IL-10 and increase in TNF-α levels in renal tissues during systemic inhibition of nitric oxide in anesthetized mice.Novel Immune Mechanisms in Hypertension and Cardiovascular Risk.Role of the adaptive immune system in hypertension.Vascular dysfunction in cerebrovascular disease: mechanisms and therapeutic intervention.Immune mechanisms in hypertension.Immune mechanisms in hypertension and vascular injury.Dysregulation of T cell subsets in the pathogenesis of hypertension.Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling.Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension.Role of MicroRNA in Endothelial Dysfunction and Hypertension.

P2860

Q24298285-9C38EA6A-DE30-4D45-B211-9114293E1BEB Q26827525-73727712-D337-44FA-8AE1-296C190EC481 Q27693834-23B8FAC9-B242-458C-8044-34FEFBADEFDD Q28079006-FC69CAB4-64C6-46BB-9DE3-261FFF214034 Q30503246-EE37039C-48EE-40A4-83B6-79BE3A65622E Q30528414-4DEE333B-868A-4A41-B999-8CBF48175E24 Q33606181-D78B75AB-EC4F-41DE-B60A-FCD7D1AD2F3F Q33785696-55BF9B5B-89EC-4EE8-9ADA-B76C0DE2F810 Q33835991-5A858993-5467-4316-9F73-F29B8BB185BF Q33888096-DC25C47B-8FD5-495F-A0DF-493A69D6157E Q34316160-2278BAE1-390B-4019-8253-3C1CA8F048AA Q34419313-204079D6-8A8F-4C61-8E76-C863B91407C8 Q34528283-80289363-9C48-4421-8EFD-642897781744 Q34538722-FF88CD3A-EA68-45D2-B7EF-B9186DC5DC7F Q34842420-2EB4E75B-8044-4365-8B07-BA856B0D9F67 Q34979773-418FF202-A5E7-4088-BF7B-8F84BADAEBC3 Q34987180-DA65D374-8A55-44D2-8BE0-60979B44D782 Q35049374-54EAE6E9-18E5-4B0F-AB57-F4A844DA17CD Q35236265-79CED427-52FA-4CD6-865E-51DEA8450281 Q35243821-90502892-173A-42E3-BE8F-C67D9AF01970 Q35759577-94843C0B-7AB8-4429-8D13-852492C43C08 Q35939300-D6ACB354-384F-4AF8-B296-9A8F1F818BBC Q36086630-59C58098-75FB-4292-8C64-EC0FF6D96432 Q36364394-F101E419-E088-4180-B69A-CDDCECA3018F Q36607837-5070E30B-CB1E-467E-B561-9B933EBC5B68 Q36660171-302838E7-A929-4B8C-9559-D6A12B6DC335 Q37059962-92B7ADE3-7E79-4FBE-85C4-B2E5673CD65F Q37096903-D88E2C2E-2C7D-43A4-BE59-9A6E7CB55146 Q37139653-6F13A3E7-2DAF-4AF5-9A06-E61C8ADD653D Q37411080-971D27FF-5E29-4C6B-971C-36FCDEE92461 Q37664105-CE45B5E3-5B34-4C21-A1A2-ECC0B9A898BF Q37683209-B422747D-013F-4E27-9E03-3010CDBC8F11 Q37694853-23668DBD-3FB3-4461-AED5-0FB2B1D1A2D5 Q37725077-4C5DA0C8-807B-493F-ABBC-B2F879C18805 Q37917624-B1790F23-A85C-4BE4-A161-563CD14C465F Q38154343-07A244F2-CADC-4889-953F-E3B74E87D95C Q38336813-4A8DB7D6-9101-43D6-8048-993F579C2990 Q38380871-666EA738-667C-499C-B1E9-B0AE8F97870C Q38948319-E8945681-FC1C-47E1-9FB6-D40CE90CFC77 Q39006068-F28CFE7E-A3C7-47F8-893B-9899DC0A85F5

P2860

Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction.

http://www.wikidata.org/entity/Q33817996

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction.

@ast

Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction.

@en

type

label

Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction.

@ast

Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction.

@en

prefLabel

Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction.

@ast

Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction.

@en

P1433

Q33817996-79AACCF9-7CA4-4730-9831-6CE4E9F5E10C

P1476

Q33817996-24D7527F-5290-4025-A477-5554170A736F

P2093

Q33817996-66C4266C-A105-4035-8045-17FCE58DB9EA

Q33817996-6B432DE4-9E0C-4339-871B-D3716102837D

Q33817996-AD8B63FE-6214-4038-A329-79EF8335CC48

Q33817996-B3F1EA78-B64B-4E5F-9FF4-25C51D6C59D8

Q33817996-CE49F417-00B4-4E6D-874B-C115535021DF

P2860

Q33817996-0D7E3EF3-6547-4DAB-B00A-8096F287DE32

Q33817996-1A70534A-26E9-4F27-9988-2BCBF684B9B5

Q33817996-1B579477-F205-4277-ADA9-7023ABE88453

Q33817996-2926F216-9A2E-454A-80E9-FF79DBC1E9E4

Q33817996-29D7C869-027F-4646-B974-BA2BDE64FB33

Q33817996-31EDAB37-FEB6-41E0-BF12-B6DBF1B91B63

Q33817996-364E92D4-50F0-4D4C-99DB-0DBD7BE39ADB

Q33817996-3BD26E1C-282F-4F5D-AEE4-973E6625CF52

Q33817996-45602492-9BBB-4D94-AC3A-791918F82886

Q33817996-5E1E79B0-5A85-4F87-BBC1-D58C77B8F218

P304

Q33817996-92A8FFD3-A7B7-43DB-87B3-6FDB7249777B

P31

Q33817996-F4E9725C-1ED6-47DC-8945-4B036DA96A16

P356

Q33817996-2B1C4BDF-8BAB-43D9-8BBC-12D9C5A33731

P407

Q33817996-EF079C2D-59C2-4F95-97A3-B33F305940BF

P433

Q33817996-5789B909-0445-4DFC-BEB3-CAC6F35F3108

P478

Q33817996-2337B68D-D680-4530-92DF-776153F994F2

P577

Q33817996-B85263E0-2A8B-4E01-853F-4C451E28E319

P698

Q33817996-68F6F4C1-5B80-4BD0-BCD5-2943F60020B9

P921

Q33817996-30641b92-e779-480c-9b08-0991e42051c0

P932

Q33817996-FE46F034-817B-48D5-BA26-2F57891CDA64

P356

HYPERTENSIONAHA.109.137158

P1433

P1476

Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction.

@en

P2093

Dale A Kinzenbaw

http://www.w3.org/2001/XMLSchema#string

Frank M Faraci

http://www.w3.org/2001/XMLSchema#string

Laura I Schrader

http://www.w3.org/2001/XMLSchema#string

Sean P Didion

http://www.w3.org/2001/XMLSchema#string

Yi Chu

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of interleukin IL-4, IL-13, IL-10, and their downstream components in lipopolysaccharide-exposed rat lungs. Comparison of the constitutive expression between rats and humans

Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.

Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice.

Glutathione peroxidase-1 plays a major role in protecting against angiotensin II-induced vascular dysfunction.

The role of oxidative stress and NADPH oxidase in cerebrovascular disease.

Interleukin-10 therapy--review of a new approach.

Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction.

Coexisting proinflammatory and antioxidative endothelial transcription profiles in a disturbed flow region of the adult porcine aorta.

Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension.

P304

619-624

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/HYPERTENSIONAHA.109.137158

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19620507

http://www.w3.org/2001/XMLSchema#string

P921

P932

2861503

http://www.w3.org/2001/XMLSchema#string